Protocol Systems (US) adds defibrillation to patient monitoring
This article was originally published in Clinica
Executive Summary
Protocol Systems (US) has acquired Omeara, a development-stage company based in Northern Ireland, for $426,000 and 145,000 shares of Protocol common stock. Omeara's primary technology - the universal defibrillator module (UDM) - and an external pacemaker will be incorporated into Protocol's Propaq Encore patient monitor and an integrated system is expected to be available in 1997.